skip to Main Content
 

Christie Teigland, PhD, Appointed to PQA Panel

  • This page as PDF

Summary

Avalere Vice President, Christie Teigland, PhD, was recently appointed to the Pharmacy Quality Alliance’s (PQA) Quality Metrics Expert Panel (QMEP) for a three-year term effective January 1, 2017.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

The QMEP is charged with making final recommendations about the endorsement of new measures. To that end, they evaluate measure concepts proposed by the PQA Measure Development Teams and Task Forces and then prioritize them for further specification and testing. They also review feedback from PQA members and the Measure Update Panel on draft measures to determine what, if any, updates need to be made to the measures. Lastly, they are responsible for evaluating the results of the pilot-testing of the draft measures. QMEP members represent a mix of quality experts from government organizations, manufacturers, pharmacy benefit managers, payers, and universities.

At Avalere, Dr. Teigland leads a team of researchers in the design and implementation of comparative effectiveness research, predictive analytics, and performance measure development and testing, including the Healthcare Effectiveness Data and Information Set measure projects awarded by NCQA.

Webinar: Decoding the CY 2025 Advance Notice Join Avalere’s healthcare policy experts as they dissect the CY 2025 Medicare Advantage Advance Notice and discuss the future trajectory of MA in Part D and potential outcomes, headwinds, and tailwinds for health plans. Learn More
Watch the Recording

Sign up to receive more insights about Quality Improvement
Please enter your email address to be notified when new Quality Improvement insights are published.

Back To Top